Jonathan Mauer Email and Phone Number
Jonathan Mauer work email
- Valid
- Valid
- Valid
Jonathan Mauer personal email
Jonathan Mauer phone numbers
I offer an extensive record of providing critical portfolio and decision analysis used to support drug development and commercialization decisions for leading pharmaceutical organizations, Pfizer and Bristol-Myers Squibb. I offer a strategic focus on applying innovation to decision analysis to advance the practice of medical benefit risk management and complex medical decision making. I gain alignment and commitment to action from stakeholders, influencing key policy decisions. I am capable of enabling Executive Leaders to make quality decisions of high-profile nature, while facing major risks. I navigate teams through challenging situations, while maintaining alignment with core business values.Specialties:Benefit/Risk Assessment | Medical Benefit/Risk | Decision ScienceDrug Development | Drug Commercialization | Strategic AlignmentPublic Policy | Regulatory Guidelines | Product Prioritization
-
Director, Medical Decision ScientistPfizer Mar 2017 - PresentNew York, New York, Us▪ Supported International Development Market Team to address threat to Toviaz reimbursement by EU Health Authority; led workshop and developed favorable benefit risk conclusion validated and published results with key opinion leaders.▪ Led benefit-risk workshop to guide submission strategy and prepare key messages for communication conclusions to regulators; provided data, key to gaining regulatory approval by assisting team in communicating acceptable level of risk for drug. ▪ Designed online self-service system, enabling teams to complete benefit risk frameworks collaboratively to improve efficiency of drafting and transferring documents into electronic regulatory submission system. ▪ Served as Pfizer Medical decision quality expert and surveyed stakeholders in medical decision forums to establish best practices and identify opportunities to enhance compliance and risk management. ▪ Devised value-based tools and processes, validated by external bioethics panel, to help company executives make difficult trade-off decisions in times of simultaneous manufacturing shortages requiring prioritization of medically necessary products.
-
Director, Portfolio & Decision AnalysisPfizer Mar 2010 - Mar 2017New York, New York, Us▪ Designed, implemented, and managed analytic processes to guide asset and portfolio strategy, seize internal/external business development opportunities, and optimize $10B portfolio. ▪ Supported enterprise R&D portfolio decision making involving allocation of $7B annual R&D budget.▪ Played key role in company’s decision to exit partnership involving under-performing brand by delivering data, building models, and developing strategic options to resolve issue between partner and Pfizer. ▪ Influenced over 6 industry approvals by guiding public policy negotiations with economic analysis supporting Generating Antibiotic Incentives Now (GAIN Act) signed into law by President Obama. ▪ Developed core elements of policy position on market-based incentives to finance healthcare innovation; represented policy position in external forums for bill under consideration in Congress. ▪ Directed Neuroscience & Pain strategy and operations planning; guided Executives’ decision to exit research in pain management, redirecting funds to higher impact projects.
-
Associate Director, R&D Operations, Resource Portfolio And Project ManagmentBristol-Myers Squibb Apr 2008 - Mar 2010Lawrence Township, Nj, Us▪ Managed $5M budget for 3 partnered early development oncology assets with 12 core team members per asset and additional external resources. -
Director Strategic Planning & Decision AnalysisBristol-Myers Squibb Sep 1999 - Apr 2008Lawrence Township, Nj, Us▪ Removed $750M from BMS R&D budget enabling portfolio diversification across multiple disease areas. ▪ Directed all aspects of Eliquis business insights analytics and assisted in guiding deal structure decision making in partnership with Pfizer. ▪ Guided complex decision making in $7.8B acquisition of DuPont by evaluating and integrating technical risk, commercial uncertainty, and R&D portfolio integration.
-
Project Manager, Information Management Associate ProgramBristol-Myers Squibb Apr 1998 - Sep 1999Lawrence Township, Nj, UsDelivered IT solutions and process improvements to customers in Clinical Development and Commercial Operations
-
Clinical PharmacistBeth Israel Medical Center Jan 1993 - Apr 1998UsPediatric & Neonatal Intensive Care Pharmacist
Jonathan Mauer Skills
Jonathan Mauer Education Details
-
St. John'S University, The Peter J. Tobin College Of BusinessFinance -
St. John'S UniversityPharmacy
-
University Of Colorado BoulderBiology
Frequently Asked Questions about Jonathan Mauer
What company does Jonathan Mauer work for?
Jonathan Mauer works for Pfizer
What is Jonathan Mauer's role at the current company?
Jonathan Mauer's current role is Decision Analysis Executive | Medical Decision Scientist.
What is Jonathan Mauer's email address?
Jonathan Mauer's email address is fr****@****ast.net
What is Jonathan Mauer's direct phone number?
Jonathan Mauer's direct phone number is +121528*****
What schools did Jonathan Mauer attend?
Jonathan Mauer attended St. John's University, The Peter J. Tobin College Of Business, St. John's University, University Of Colorado Boulder.
What skills is Jonathan Mauer known for?
Jonathan Mauer has skills like Decision Analysis, Forecasting, Portfolio Management, R&d, Pharmaceutical Industry, Oncology, Biotechnology, Clinical Development, Clinical Trials, Drug Development, Lifesciences, Competitive Intelligence.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial